240 related articles for article (PubMed ID: 9498800)
1. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
[TBL] [Abstract][Full Text] [Related]
2. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
Gray JD; Hirokawa M; Ohtsuka K; Horwitz DA
J Immunol; 1998 Mar; 160(5):2248-54. PubMed ID: 9498764
[TBL] [Abstract][Full Text] [Related]
3. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N
Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta.
Ohtsuka K; Gray JD; Quismorio FP; Lee W; Horwitz DA
Lupus; 1999; 8(2):95-102. PubMed ID: 10192502
[TBL] [Abstract][Full Text] [Related]
5. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Kanda N; Tsuchida T; Tamaki K
Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
[TBL] [Abstract][Full Text] [Related]
6. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.
Linker-Israeli M; Deans RJ; Wallace DJ; Prehn J; Ozeri-Chen T; Klinenberg JR
J Immunol; 1991 Jul; 147(1):117-23. PubMed ID: 2051017
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
Kanda N; Watanabe S
J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
[TBL] [Abstract][Full Text] [Related]
9. The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity.
Ohtsuka K; Gray JD; Stimmler MM; Horwitz DA
Lupus; 1999; 8(2):90-4. PubMed ID: 10192501
[TBL] [Abstract][Full Text] [Related]
10. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
Eriksson M; Meadows SK; Wira CR; Sentman CL
J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
12. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
[TBL] [Abstract][Full Text] [Related]
13. Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMC.
Linker-Israeli M; Honda M; Nand R; Mandyam R; Mengesha E; Wallace DJ; Metzger A; Beharier B; Klinenberg JR
Clin Immunol; 1999 Apr; 91(1):6-16. PubMed ID: 10219249
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
17. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
18. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
Huang YP; Perrin LH; Miescher PA; Zubler RH
J Immunol; 1988 Aug; 141(3):827-33. PubMed ID: 3135313
[TBL] [Abstract][Full Text] [Related]
19. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]